New book by Larry Connors Click here Improve your trading - See how
"We were very excited to become the first hospital in India to introduce RapidArc treatments earlier this year and the results so far give us great satisfaction," says Dheeraj Gorukanti, chief executive officer of Yashoda Hospitals Group. "We believe it has the potential to be better than conventional IMRT treatments for many cases of cancer and going forward our clinical team intends to use RapidArc on a majority of patients."
"RapidArc provides highly conformal dose distributions which can be delivered very quickly," said Dr. G Surender Rao, executive director at Yashoda Cancer Institute, which has now delivered more than 100 treatments with the new technology. "The majority of patients we have treated with RapidArc to date have been head & neck and cervical cancer patients. Cervical cancer is the number one indication for women in India but treating it with standard radiotherapy or brachytherapy is sometimes time-consuming. RapidArc gives highly conformal dose distributions which can be delivered in a very short space of time, enhancing patient comfort and offering a high quality treatment."
RapidArc delivers a precise and efficient treatment in single or multiple arcs of the treatment machine around the patient and makes it possible to deliver image-guided intensity modulated radiotherapy (IMRT) two to eight times faster than is possible with conventional IMRT. Faster treatments allow for greater precision, since there is less chance of patient or tumor movement during treatment delivery and, with less time on the treatment couch, also allow for greater patient comfort.Conventional IMRT treatments are slower and more difficult for radiotherapy radiographers because they target tumors using a complex sequence of fixed beams from multiple angles.
The private Yashoda Cancer Institute treats 9,000 patients per annum and serves a patient population of 70 million people in Hyderabad and the entire state of Andhra Pradesh, as well as the neighboring states of Karnataka, Maharastra and Orissa. "Rising cancer rates in India make it vital that the country's cancer centers utilize the most advanced radiotherapy tools to combat the disease," says Dheeraj Gorukanti.
"Cancer rates have increased many fold in the last few decades because of increased and earlier detection methods, increased life expectancy resulting from successful treatment of infectious diseases and advances and medicine, and an increase in unhealthy lifestyles," says Dheeraj Gorukanti. "In India we need treatment capabilities as anywhere in the world to fight this disease."
Rolf Staehelin, Varian's marketing director in Europe and India, says, "Yashoda was the first hospital in India to introduce both conventional IMRT and RapidArc and to treat 100 patients with RapidArc in such as short space of time is a great achievement."
Yashoda played host to the country's first international RapidArc Symposium in early October when more than 200 people attended a hands-on RapidArc course and symposium at the hospital. Clinicians from Italy, Switzerland, the Netherlands and the U.S. presented their experiences in delivering advanced RapidArc volumetric modulated arc therapy treatments.
About Varian Medical Systems
Varian Medical Systems, Inc., of Palo Alto, California, is the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy, and brachytherapy. The company supplies informatics software for managing comprehensive cancer clinics, radiotherapy centers and medical oncology practices. Varian is a premier supplier of tubes and digital detectors for X-ray imaging in medical, scientific, and industrial applications and also supplies X-ray imaging products for cargo screening and industrial inspection. Varian Medical Systems employs approximately 5,100 people who are located at manufacturing sites in North America, China, and Europe and in its 79 sales and support offices around the world.
Varian Medical Systems UK Limited.Registered in England.
Registration No: 558526. Registered office address: Gatwick Road, Crawley, West Sussex RH10 9RG
CONTACT: Neil Madle, Varian Medical Systems Tel: +44 (0)7786 526 068 WWW: http://www.varian.com/
((M2 Communications disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.
More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index
About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback
The Connors Group, Inc. ("Company") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should buy or sell for themselves. The analysts and employees or affiliates of Company may hold positions in the stocks, currencies or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities and/or currencies. The Company, the authors, the publisher, and all affiliates of Company assume no responsibility or liability for your trading and investment results. Factual statements on the Company's website, or in its publications, are made as of the date stated and are subject to change without notice.
It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by Company are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of Company's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on Company's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.
HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN INHERENT LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING AND MAY NOT BE IMPACTED BY BROKERAGE AND OTHER SLIPPAGE FEES. ALSO, SINCE THE TRADES HAVE NOT ACTUALLY BEEN EXECUTED, THE RESULTS MAY HAVE UNDER- OR OVER-COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFITS OR LOSSES SIMILAR TO THOSE SHOWN.
The Connors Group, Inc.
10 Exchange Place, Suite 1800
Jersey City, NJ 07302
© Copyright 2009 The Connors Group, Inc.
